Septerna
South San Francisco, US · 5 known investors
Septerna develops oral small molecule drug candidates targeting G protein-coupled receptors (GPCRs) using its proprietary Native Complex Platform. The company's pipeline focuses on endocrinology, immunology and inflammation, and metabolic diseases for patients with unmet medical needs.
BiotechDeep Tech
Investors · 5
Frequently asked questions
- What does Septerna do?
- Septerna develops oral small molecule drug candidates targeting G protein-coupled receptors (GPCRs) using its proprietary Native Complex Platform. The company's pipeline focuses on endocrinology, immunology and inflammation, and metabolic diseases for patients with unmet medical needs.
- Who are Septerna's investors?
- Septerna's investors include Catalio Capital Management, LP, RA Capital, Samsara BioCapital, Vertex Ventures HC, Third Rock Ventures.
- Where is Septerna headquartered?
- Septerna is headquartered in South San Francisco, US.